关于海洛因使用的蛋白质分子见解:与神经退行症的联系
Mustafa Gani Sürmen1, Sadrettin Pence2, Saime Sürmen1
1Department of Molecular Medicine, Hamidiye Institute of Health Sciences, University of Health Sciences, Istanbul, Turkey.
Molecular neurobiology
|February 20, 2026
概括
吸食海洛因会导致人类大脑发生显著的分子变化,影响海马和骨等关键区域的蛋白质表达. 这些变化与神经退行和神经元功能受损有关.
科学领域:
- 神经科学是一个神经科学.
- 蛋白质组学是指蛋白质组学.
- 分子生物学分子生物学
背景情况:
- 由于使用海洛因,对大脑中的分子变化的理解有限.
- 海洛因依赖会影响各种生理系统,包括中枢神经系统.
研究的目的:
- 为了研究在特定的死后人类大脑区域的海洛因依赖分子变化.
- 识别差异表达蛋白 (DEP) 和它们的功能影响.
主要方法:
- 使用高分辨率液体色谱-电喷射电离-并联质谱 (LC-ESI-MS/MS) 的蛋白质组分析.
- 对海马,面和尾状核组织进行无标签的定量分析.
- 蛋白与蛋白相互作用 (PPI) 网络和基因本体学 (GO) 丰富分析.
主要成果:
- 在海马体中有87种蛋白质的显著差异性表达,121种在膜中,80种在尾状核中.
- 增强PPI网络,并确定细胞外外体,细胞外空间和囊泡作为关键细胞组件.
- 信号传递,结合和与压力相关的分子功能的改变;在每个区域观察到的特定蛋白质表达变化.
结论:
- 吸食海洛因会在人脑中引起广泛的分子变化,影响神经元功能.
- 鉴定的蛋白质变化表明氧化应激增加和神经退行.
- 这些发现有助于了解海洛因神经毒性作用和潜在治疗点的分子基础.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
1.3K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.3K
Drugs Affecting Neurotransmitter Synthesis
2.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.3K
Neurochemical Transmission: Sites of Drug Action
3.7K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.7K
Drug Dependence
1.8K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.8K
Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
Opioid Receptors: Overview
5.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.1K


